SpliceBio, a clinical-stage genetic medicines company pioneering protein splicing to address diseases caused by mutations in large genes, today announced that the first patient has been dosed in the ...

Although the participation of spliceosomes is almost always required for intron removal, a few types of genes have self-splicing RNA introns.